Advances in Pharmacy Practice

Welcome to Pharmacy Fall Conference

This virtual conference was captured from the annual conference and is aimed at enhancing the knowledge and skill level of practicing pharmacists. Educational offerings have been designed to balance both broad primary and acute care scenarios. Topics and presenters have been selected to maximize practical knowledge and to empower participants to apply concepts within their own practices. Emphasis has been placed on therapeutic areas where recent advances or gains in knowledge have expanded current treatment guidelines.

The virtual conference can be viewed at no charge without CME or CPE credit. For those seeking credit, the activities can be purchased as a course for a fee of $60 or taken as individual offerings for a fee of $5 each. The individual offerings are listed below or you may purchase the entire conference up front by clicking "Purchase Now".

Activity Details

  • Credit Amounts:
    • CPE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Oct 23, 2017
  • Cost: $5.00
Learn More »

Kentucky Pharmacy Law Review 2014

These topics were chosen as the law regarding how long a prescription must be kept was updated in Regulation as of January 2012 and Pharmacists need to understand the process and their rights when a complaint is filed against them.

Activity Details

  • Credit Amounts:
    • CPE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Oct 23, 2017
  • Cost: $5.00
Learn More »

Diabetes Update 2014

Diabetes affects 29 million people or 9.3% of the US population.  By 2050, the prevalence of total diabetes is projected to increase from 1 in 10 adults to between 1 in 5 and 1 in 3 adults in the US.  Poor glycemic control has a well-established predictive value for the risk of diabetes-related complications. Despite this correlation, almost half of US adults with...

Activity Details

  • Credit Amounts:
    • CPE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Oct 23, 2017
  • Cost: $5.00
Learn More »

Expanding Our Armamentarium Against Gram-Positive Infections: An Update on Newly Approved Antimicrobials

Resistant gram positive organisms are a continuing threat related to both community-onset and hospital-acquired infections. Three new antimicrobial agents have been recently approved against resistant pathogens and each agent presents a unique challenge in order to ensure its proper use in clinical practice.

Activity Details

  • Credit Amounts:
    • CPE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Oct 23, 2017
  • Cost: $5.00
Learn More »

PEP - Post Exposure Prophylaxis

A new update from the US Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis that providers may not be familiar with include the following:
- Prompt management of occupational exposures
- Selection of effective / tolerable PEP regimens
- Potential toxicities /interactions of PEP...

Activity Details

  • Credit Amounts:
    • CPE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Oct 23, 2017
  • Cost: $5.00
Learn More »

Novel Oral Anticoagulants: What is the Role of the Pharmacist?

Need: Novel oral anticoagulants are increasing in use and pharmacists need to be aware of efficacy and safety issues.

Gap: In the past, oral anticoagulation therapy had limited options (e.g., warfarin) but novel oral anticoagulants provide an alternative therapy and require additional education to use in current practice.

Activity Details

  • Credit Amounts:
    • CPE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Oct 23, 2017
  • Cost: $5.00
Learn More »

Understanding and Navigating Testosterone and Its Replacement

Rapid approval of various testosterone products as well as replacement guidelines has created a need for better education in this area. This is underscored by recent research linking testosterone replacement to cardiovascular morbidity.

Several new testosterone products are now available. These agents vary by route, effect, adverse effects, and cost. Each product requires...

Activity Details

  • Credit Amounts:
    • CPE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Oct 23, 2017
  • Cost: $5.00
Learn More »

Herpes Zoster (Shingles) and Zostavax®

Suboptimal screening and recommendation of herpes zoster vaccination has led to below goal vaccination rates in patients indicated for the vaccine. Healthcare providers as a whole must work together to increase the recommendations and administrations of vaccines. Pharmacy must use its accessibility to aid in increasing vaccination rates, particularly herpes zoster vaccination.

Activity Details

  • Credit Amounts:
    • CPE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Oct 23, 2017
  • Cost: $5.00
Learn More »

Pediatric Asthma Update: Implementing a Successful Plan for Our Children

The difference between current practice and optimal practice relevant to the educational need is to make pharmacists and techs feel more confident about their role in adherence and management of pediatric asthma. A better review of device, drug delivery and treatment guidelines for pediatric asthma are needed.

Activity Details

  • Credit Amounts:
    • CPE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Oct 23, 2017
  • Cost: $5.00
Learn More »

The Magic Bullet Against Leukemia: An Update on Tyrosine Kinase Inhibitors

With the approval in many countries of nilotinib and dasatinib for frontline therapy in chronic myeloid leukemia, clinicians now have to make a difficult choice. Because none of the 3 available tyrosine kinase inhibitors (TKIs) have shown a clear survival advantage, they all represent reasonable choices. However, in individual patients, the case may be stronger for a particular...

Activity Details

  • Credit Amounts:
    • CPE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Oct 23, 2017
  • Cost: $5.00
Learn More »

Hepatitis C Update

Hepatitis C virus (HCV) infection is the most common chronic bloodborne infection in the United States; approximately 3.2 million persons are chronically infected. Although HCV is not efficiently transmitted sexually, persons at risk for infection through injection drug use might seek care in STD treatment facilities, HIV counseling and testing facilities, correctional facilities,...

Activity Details

  • Credit Amounts:
    • CPE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Oct 23, 2017
  • Cost: $5.00
Learn More »

What's New in the Management of Heart Failure?

Heart failure is a rapidly evolving field and a disease process that is rapidly increasing in the population; new treatment guidelines have been published and its important for the pharmacist to maintain competency & stay abreast of novel therapies/literature to provide optimal patient outcomes.

Activity Details

  • Credit Amounts:
    • CPE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Oct 23, 2017
  • Cost: $5.00
Learn More »

A Practical Guide to Managing the 340b Program in Your Pharmacy

The 340B Drug Pricing Program requires drug manufacturers to provide outpatient drugs to eligible health care organizations/covered entities at significantly reduced prices.

The 340B Program enables covered entities to stretch scarce Federal resources as far as possible, reaching more eligible patients and providing more comprehensive services*. Understanding the importance...

Activity Details

  • Credit Amounts:
    • CPE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Oct 23, 2017
  • Cost: $5.00
Learn More »

Contemporary Management of Clostridium difficile Associated Diarrhea: A Pharmacist’s Role

Clostridium difficile infections are a growing problem in US health systems and contributing to increases in morbidity and mortality. Novel treatment strategies are available, but with limited clinical experience the need for further understanding of these strategies will help clinicians mange patients with c. difficile associated diarrhea.

Activity Details

  • Credit Amounts:
    • CPE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Oct 23, 2017
  • Cost: $5.00
Learn More »

Alzheimer’s Disease: Current and Future Treatments

Alzheimer’s disease (AD) is a common disorder with limited treatment modalities.  Practitioners must understand current treatments and those in development to improve quality of pharmaceutical use for AD.